TY - JOUR
T1 - Three-dimensional treatment planning and conformal radiation therapy
T2 - preliminary evaluation
AU - Perez, Carlos A.
AU - Purdy, James A.
AU - Harms, William
AU - Gerber, Russell
AU - Graham, Mary V.
AU - Matthews, John W.
AU - Bosch, Walter
AU - Drzymala, Robert
AU - Emami, Bahman
AU - Fox, Seymour
AU - Klein, Eric
AU - Lee, Henry K.
AU - Michalski, Jeff M.
AU - Simpson, Joseph R.
PY - 1995/7
Y1 - 1995/7
N2 - Preliminary clinical results are presented for 209 patients with cancer who had treatment planned on our three-dimensional radiation treatment planning (3-D RTP) system and were treated with external beam conformal radiation therapy. Average times (min) for CT volumetric simulation were: 74 without or 84 with contrast material; 36 for contouring of tumor/target volume and 44 for normal anatomy; 78 for treatment planning; 53 for plan evaluation/optimization; and 58 for verification simulation. Average time of daily treatment sessions with 3-D conformal therapy or standard techniques was comparable for brain, head and neck, thoracic, and hepatobiliary tumors (11.8-14 min and 11.5-12.1, respectively). For prostate cancer patients treated with 3-D conformal technique and Cerrobend blocks, mean treatment time was 19 min; with multileaf collimation it was 14 min and with bilateral arc rotation, 9.8 min. Acute toxicity was comparable to or lower than with standard techniques. Sophisticated 3-D RTP and conformal irradiation can be performed in a significant number of patients at a reasonable cost. Further efforts, including dose-escalation studies, are necessary to develop more versatile and efficient 3-D RTP systems and to enhance the cost benefit of this technology in treatment of patients with cancer.
AB - Preliminary clinical results are presented for 209 patients with cancer who had treatment planned on our three-dimensional radiation treatment planning (3-D RTP) system and were treated with external beam conformal radiation therapy. Average times (min) for CT volumetric simulation were: 74 without or 84 with contrast material; 36 for contouring of tumor/target volume and 44 for normal anatomy; 78 for treatment planning; 53 for plan evaluation/optimization; and 58 for verification simulation. Average time of daily treatment sessions with 3-D conformal therapy or standard techniques was comparable for brain, head and neck, thoracic, and hepatobiliary tumors (11.8-14 min and 11.5-12.1, respectively). For prostate cancer patients treated with 3-D conformal technique and Cerrobend blocks, mean treatment time was 19 min; with multileaf collimation it was 14 min and with bilateral arc rotation, 9.8 min. Acute toxicity was comparable to or lower than with standard techniques. Sophisticated 3-D RTP and conformal irradiation can be performed in a significant number of patients at a reasonable cost. Further efforts, including dose-escalation studies, are necessary to develop more versatile and efficient 3-D RTP systems and to enhance the cost benefit of this technology in treatment of patients with cancer.
KW - 3-D CT simulation
KW - 3-D treatment planning
KW - Conformal irradiation
KW - Radiation therapy planning
UR - http://www.scopus.com/inward/record.url?scp=0029145668&partnerID=8YFLogxK
U2 - 10.1016/0167-8140(95)01566-Y
DO - 10.1016/0167-8140(95)01566-Y
M3 - Article
C2 - 8525023
AN - SCOPUS:0029145668
SN - 0167-8140
VL - 36
SP - 32
EP - 43
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
IS - 1
ER -